LIR生命科学组织于2025年12月18日任命Peter Singer博士为科学顾问,以推动其生物技术和药物开发工作。 LIR Life Sciences named Dr. Peter Singer scientific advisor on Dec. 18, 2025, to boost its biotech and drug development efforts.

LIR生命科学已任命Peter Singer博士为科学顾问, LIR Life Sciences has appointed Dr. Peter Singer as a scientific advisor, bringing his expertise to the company’s research and development efforts. 2025年12月18日的公告突显了辛格在生命科学方面的广泛背景以及他对推动医学创新的贡献。 The announcement, made on December 18, 2025, highlights Singer’s extensive background in life sciences and his contributions to advancing medical innovation. 他的作用将支持该公司在生物技术和药物开发方面的战略举措。 His role will support the company’s strategic initiatives in biotechnology and drug development.